Structure-based virtual screening of Src kinase inhibitors.
暂无分享,去创建一个
Kyungik Lee | Ji Yeon Song | K. Jeong | Yangmee Kim | Ki Won Lee | Yangmee Kim | Maeng Sup Kim | Gwan Sun Lee | Jongwoo Kim | Ki-Woong Jeong | Yeonjoo Lee | M. Kim | Kyungik Lee | Jongwoo Kim | Yeonjoo Lee
[1] Ping Chen,et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. , 2004, Journal of medicinal chemistry.
[2] T. Boggon,et al. Structure and regulation of Src family kinases , 2004, Oncogene.
[3] Sheila M. Thomas,et al. Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.
[4] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[5] G. Gallick,et al. Src family kinases in tumor progression and metastasis , 2003, Cancer and Metastasis Reviews.
[6] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[7] E. Avizienyte,et al. Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior. , 2005, Cancer research.
[8] T. Hunter,et al. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine , 1980, Proceedings of the National Academy of Sciences.
[9] J. Parsons,et al. Src family kinases, key regulators of signal transduction , 2004, Oncogene.
[10] D. Boschelli,et al. Synthesis and Src kinase inhibitory activity of 2-phenyl- and 2-thienyl-7-phenylaminothieno[3,2-b]pyridine-6-carbonitriles. , 2005, Journal of medicinal chemistry.
[11] Ajay,et al. Computational methods to predict binding free energy in ligand-receptor complexes. , 1995, Journal of medicinal chemistry.
[12] J. Mestan,et al. Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia. , 2005, Biochimica et biophysica acta.
[13] Qian Huang,et al. The Discovery of Novel Vascular Endothelial Growth Factor Receptor Tyrosine Kinases Inhibitors: Pharmacophore Modeling, Virtual Screening and Docking Studies , 2007, Chemical biology & drug design.
[14] L. Otterbein,et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. , 2006, Journal of medicinal chemistry.
[15] Fei Ye,et al. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models. , 2005, Cancer research.
[16] Susan Adams,et al. Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds , 2006, Chemical biology & drug design.
[17] Robert Huber,et al. Crystal structures of active SRC kinase domain complexes. , 2005, Journal of molecular biology.
[18] P. Schwartzberg,et al. The many faces of Src: multiple functions of a prototypical tyrosine kinase , 1998, Oncogene.
[19] Yuzhu Chen,et al. N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2. , 2004, Journal of medicinal chemistry.
[20] Renxiao Wang,et al. Comparative evaluation of 11 scoring functions for molecular docking. , 2003, Journal of medicinal chemistry.
[21] D. Boschelli,et al. Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity. , 2001, Journal of medicinal chemistry.
[22] Thierry Langer,et al. Impact of Scoring Functions on Enrichment in Docking-Based Virtual Screening: An Application Study on Renin Inhibitors , 2004, J. Chem. Inf. Model..
[23] P. Plé,et al. Discovery of a new class of anilinoquinazoline inhibitors with high affinity and specificity for the tyrosine kinase domain of c-Src. , 2004, Journal of medicinal chemistry.
[24] J. Siegfried,et al. Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells , 2004, Cancer Research.
[25] D. Fabbro,et al. The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation. , 2005, Structure.
[26] Tudor I. Oprea,et al. Integrating virtual screening in lead discovery. , 2004, Current opinion in chemical biology.
[27] D. Rognan,et al. Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. , 2000, Journal of medicinal chemistry.
[28] S. Wedge,et al. Novel 4-anilinoquinazolines with C-7 basic side chains: design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitors. , 2002, Journal of medicinal chemistry.